Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress by S. Bhatia, D. Davar, S. Thomas, A.W. Silk, R.C. Wu, R. Ladwa, S.J. Park, C.M. Kelly, D.J. Wong, J. Grewal, N. Vohra, A.M. Lim, J. Puegero, C. Verschraegen, B. Zhong, I. Lowy, M. Fury, M. Cristea

Get full text